Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort

被引:15
|
作者
Zanatta, Elisabetta [1 ]
Cocconcelli, Elisabetta [2 ]
Castelli, Gioele [2 ]
Giraudo, Chiara [3 ]
Fraia, Anna Sara [3 ]
De Zorzi, Elena [2 ]
Gatto, Mariele [1 ]
Ienna, Luana [1 ]
Treppo, Elena [4 ]
Malandrino, Danilo [5 ,6 ,7 ]
Cereser, Lorenzo [8 ]
Emmi, Giacomo [5 ,6 ,7 ,9 ]
Giannelli, Federico [10 ]
Bellani, Serena [2 ]
Martini, Andrea [11 ]
Moccaldi, Beatrice [1 ]
Ghirardello, Anna [1 ]
Avouac, Jerome [12 ]
Quartuccio, Luca [4 ]
Allanore, Yannick [12 ]
Doria, Andrea [1 ]
Spagnolo, Paolo [2 ]
Balestro, Elisabetta [2 ]
Iaccarino, Luca [1 ]
机构
[1] Padova Univ Hosp, Dept Med DIMED, Rheumatol Unit, Padua, Italy
[2] Padova Univ Hosp, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Resp Dis Unit, Padua, Italy
[3] Padova Univ Hosp, Dept Med DIMED, Unit Adv Clin & Translat Imaging, Padua, Italy
[4] Univ Udine, Acad Hosp Santa Maria Misericordia, Dept Med DAME, Div Rheumatol,ASUFC, Udine, Italy
[5] Univ Firenze, Dept Expt & Clin Med, Florence, Italy
[6] AOU Careggi Hosp Florence, Behcet Ctr, Interdisciplinary Internal Med Unit, Florence, Italy
[7] AOU Careggi Hosp Florence, Lupus Clin, Florence, Italy
[8] Univ Udine, Acad Hosp Santa Maria Misericordia, Inst Radiol, Dept Med DAME,ASUFC, Udine, Italy
[9] Monash Univ, Ctr Inflammatory Dis, Monash Med Ctr, Dept Med, Clayton, Vic, Australia
[10] Mugello Hosp, Azienda USL Toscana Ctr, Dept Radiol, Borgo San Lorenzo, Italy
[11] Univ Teaching Hosp Padova, Dept Med, Unit Internal Med & Hepatol, Padua, Italy
[12] Univ Paris Cite, Hop Cochin, AP HP, Serv Rhumatol,Fac Sante, Paris, Ile De France, France
来源
RMD OPEN | 2023年 / 9卷 / 03期
关键词
polymyositis; pulmonary fibrosis; dermatomyositis; autoimmune diseases; CLASSIFICATION;
D O I
10.1136/rmdopen-2023-003121
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesPatients with connective tissue diseases can develop interstitial lung disease (ILD), leading to a progressive fibrosing ILD (PF-ILD) phenotype in some cases. We aimed to investigate the occurrence of PF-ILD in idiopathic inflammatory myopathies (IIMs), and factors potentially predicting this phenotype. Secondary aims were to assess the radiological pattern and factors associated with IIMs-ILD. MethodsPatients with IIMs from our multicentric prospective cohort were retrospectively evaluated. Data were recorded at IIMs and ILD diagnosis, and during follow-up. Patients with ILD were classified according to the predominant high-resolution CT (HRCT) pattern: non-specific interstitial pneumonia (NSIP), usual interstitial pneumonia (UIP) and organising pneumonia (OP). PF-ILD was defined according to the 2022 American Thoracic Society (ATS), European Respiratory Society (ERS), Japanese Respiratory Society (JRS) and Latin American Thoracic Society (ALAT) guidelines. Univariate and multivariate analyses were performed to identify factors associated to ILD and to PF-ILD. ResultsOf 253 patients with IIMs, 125 (49%) had ILD: 99 (78%) at IIMs diagnosis and 26 (22%) during follow-up (21/26 within 5 years). Multivariate analysis identified anti-Jo-1, anti-MDA5, anti-Ro52, high score on manual muscle test, mechanic's hands and Raynaud's phenomenon as independently associated with ILD. The predominant HRCT pattern was NSIP (50% of patients), followed by UIP (28%) and OP (22%). At 1-year follow-up, PF-ILD occurred in 18% of IIMs-ILD. PF-ILD was predicted by anti-MDA5, heliotropic rash, xerostomia and xerophthalmia at univariate but not at multivariate analysis. ConclusionPatients with IIM should be carefully screened for ILD at IIMs diagnosis and yearly during follow-up. All patients with IIMs-ILD should be carefully monitored to capture ILD progression since a consistent proportion of them are expected to develop PF-ILD.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] CCL-18 AS A BIOMARKER OF INTERSTITIAL LUNG DISEASE (ILD) AND PROGRESSIVE FIBROSING ILD IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES
    Zanatta, E.
    Depascale, R.
    Gamba, A.
    Tonello, M.
    Martini, A.
    Gatto, M.
    Doria, A.
    Iaccarino, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 943 - 944
  • [2] CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies
    Zanatta, Elisabetta
    Martini, Andrea
    Depascale, Roberto
    Gamba, Anna
    Tonello, Marta
    Gatto, Mariele
    Giraudo, Chiara
    Balestro, Elisabetta
    Doria, Andrea
    Iaccarino, Luca
    DIAGNOSTICS, 2023, 13 (10)
  • [3] Prognostic significance of natural killer cell depletion in predicting progressive fibrosing interstitial lung disease in idiopathic inflammatory myopathies
    Shao, Chenyi
    Xia, Nana
    Zhen, Yan
    Zhang, Xueliang
    Yan, Ninghui
    Guo, Qiang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [4] IDIOPATHIC INFLAMMATORY MYOPATHIES & INTERSTITIAL LUNG DISEASE
    Ciang, N.
    Ng, R.
    Leung, A.
    Chan, J.
    Kwok, K.
    Ho, G.
    Ho, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 124 - 124
  • [5] Interstitial lung disease in idiopathic inflammatory myopathies
    Lam, Luk Ping
    Loretta
    Yam, Yin Chun
    Miu, Pui Ling
    RESPIROLOGY, 2024, 29 : 118 - 118
  • [6] RITUXIMAB IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES ASSOCIATED WITH INTERSTITIAL LUNG DISEASE
    Khelkovskaya-Sergeeva, A. N.
    Antelava, O. A.
    Olyunin, Y. A.
    Tarasova, G. M.
    Lopatina, N. E.
    Palshina, S. E.
    Sazhina, E. G.
    Nikonorova, N. O.
    Koneva, O. A.
    Alexandrovna, E. N.
    Nasonov, E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 741 - 742
  • [7] A Cohort of Patients with a Progressive Fibrosing Phenotype of Interstitial Lung Disease (PF-ILD) Other Than Idiopathic Pulmonary Fibrosis: The Progress Study
    Cottin, V.
    Larrieu, S.
    Fabre, C.
    Si-Mohamed, S.
    Ahmad, K.
    Boussel, L.
    Brevet, M.
    Marque, S.
    Revel, D.
    Thivolet-Bejui, F.
    Traclet, J.
    Zeghmar, S.
    Maucort-Boulch, D.
    Nasser, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [8] Care patterns of patients with chronic fibrosing interstitial lung disease (ILD) with a progressive phenotype
    Nili, Mona
    Singer, David
    Hanna, Maya
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [9] Care patterns of patients with chronic fibrosing interstitial lung disease (ILD) with a progressive phenotype
    Mona Nili
    David Singer
    Maya Hanna
    BMC Pulmonary Medicine, 22
  • [10] SYSTEMATIC LITERATURE REVIEW OF TREATMENTS FOR INTERSTITIAL LUNG DISEASE IN PATIENTS WITH A PROGRESSIVE FIBROSING PHENOTYPE
    Rohr, K. B.
    Baldwin, M.
    Sabry-Grant, C.
    Langford, B.
    Salih, F.
    Diamantopoulos, A.
    Cottin, V
    VALUE IN HEALTH, 2020, 23 : S716 - S716